{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:36:53Z","timestamp":1773970613517,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2019611"],"award-info":[{"award-number":["BE2019611"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a highly heterogeneous neurodegenerative disorder with varying clinical subtypes. Recently, a novel classification called MNCD (Motor\/Non-motor\/Cognition\/Dependency) has been proposed, which can also include staging based on disease severity. We aim to investigate which staging, the MNCD classification and staging or Hoehn and Yahr (H&amp;Y) staging, exhibits a stronger correlation with the 39-item Parkinson\u2019s Disease Questionnaire (PDQ-39). In a cross-sectional study conducted at our single center, 357 PD patients were recruited. Data encompassed scores from various assessments such as the Movement Disorder Society of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS) Parts I, II, III and IV, Montreal Cognitive Assessment (MoCA), PDQ-39, and the H&amp;Y scale. The mean age of these patients was 66.4\u2009\u00b1\u20099.1 years old, and the majority (54.6%) were male. MNCD stages: stage 1 (<jats:italic>N<\/jats:italic>\u2009=\u20093, 0.8%), stage 2 (<jats:italic>N<\/jats:italic>\u2009=\u200962, 17.4%), stage 3 (<jats:italic>N<\/jats:italic>\u2009=\u2009187, 52.4%), stage 4 (<jats:italic>N<\/jats:italic>\u2009=\u200986, 24.1%), and stage 5 (<jats:italic>N<\/jats:italic>\u2009=\u200919, 5.3%). The top 5 most frequent PD-related clinical symptoms were sleep disturbances (89.6%), fatigue (69.7%), mild cognitive impairment (68.9%), constipation (65.8%), and postural instability (65.5%). The PDQ-39 demonstrated a positive correlation with both MNCD staging and H&amp;Y staging. Moreover, the MNCD staging exhibited a stronger correlation with PDQ-39 compared to H&amp;Y staging. The correlation between the MNCD classification and staging with the quality of life in PD patients is more statistically significant compared to the H&amp;Y staging.<\/jats:p>","DOI":"10.1007\/s00702-024-02756-4","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:01:50Z","timestamp":1711645310000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation between the MNCD classification-based staging of Parkinson\u2019s disease and quality of life: a cross-sectional study"],"prefix":"10.1007","volume":"131","author":[{"given":"Guixiang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingru","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haicun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5916-9837","authenticated-orcid":false,"given":"Weiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"issue":"5","key":"2756_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/nmt-2020-0021","volume":"10","author":"J ALDRED","year":"2020","unstructured":"Aldred J, Anca-Herschkovitsch M, Antonini A et al (2020) Application of the \u20185-2-1\u2019 screening criteria in advanced Parkinson\u2019s disease: interim analysis of DUOGLOBE [J]. Neurodegenerative Disease Manage 10(5):309\u2013323. https:\/\/doi.org\/10.2217\/nmt-2020-0021","journal-title":"Neurodegenerative Disease Manage"},{"key":"2756_CR34","doi-asserted-by":"publisher","unstructured":"Antonini A, Odin P, Schmidt P, Cubillos F, Standaert DG, Henriksen T, Jimenez-Shahed J, Alobaidi A, Jalundhwala YJ, Bao Y, Zamudio J (2021) Validation and clinical value of the MANAGE-PD tool: a clinician-reported tool to identify parkinson\u2019s disease patients inadequately controlled on oral medications [J]. Parkinsonism Relat Disord 92:59\u201366. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.10.009","DOI":"10.1016\/j.parkreldis.2021.10.009"},{"issue":"6","key":"2756_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MS ARMSTRONG M J, OKUN","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson Disease: a review [J]. JAMA 323(6):548\u2013560","journal-title":"JAMA"},{"issue":"10291","key":"2756_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"KLEINC BLOEM B R, OKUN M S","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease [J]. Lancet (London England) 397(10291):2284\u20132303","journal-title":"Lancet (London England)"},{"issue":"11","key":"2756_CR17","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/mds.21567","volume":"22","author":"J DEN OUDSTEN B L, VAN HECK G L, DE V","year":"2007","unstructured":"Den Oudsten BL, Van Heck GL, De Vries J (2007) Quality of life and related concepts in Parkinson\u2019s disease: a systematic review [J]. Mov Disord 22(11):1528\u20131537","journal-title":"Mov Disord"},{"key":"2756_CR29","unstructured":"Galeoto G, Berardi A, Colalelli F et al (2022) Correlation between Quality of Life and severity of Parkinson\u2019s Disease by assessing an optimal cut-off point on the Parkinson\u2019s Disease questionnaire (PDQ-39) as related to the Hoehn & Yahr (H&Y) scale [J], vol 173. La Clinica terapeutica, pp 243\u2013248. 3"},{"issue":"9","key":"2756_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"G GOETZ C","year":"2004","unstructured":"Goetz CG, Poewe W (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations [J]. Mov Disord 19(9):1020\u20131028 https:\/\/doi.org\/10.1002\/mds.20213","journal-title":"Mov Disord"},{"issue":"15","key":"2756_CR13","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"GOETZ C G","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results [J]. Mov Disord 23(15):2129\u20132170","journal-title":"Mov Disord"},{"issue":"4","key":"2756_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/mds.27323","volume":"33","author":"I GOLDMAN J G, HOLDEN S K, LITVAN","year":"2018","unstructured":"Goldman JG, Holden SK, Litvan I et al (2018) Evolution of diagnostic criteria and assessments for Parkinson\u2019s disease mild cognitive impairment [J]. Mov Disord 33(4):503\u2013510","journal-title":"Mov Disord"},{"issue":"5","key":"2756_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MD HOEHN M M, YAHR","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality [J]. Neurology 17(5):427\u2013442","journal-title":"Neurology"},{"issue":"2","key":"2756_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","volume":"50","author":"S HUGHES A J, DANIEL S E, BLANKSON","year":"1993","unstructured":"Hughes AJ, Daniel SE, Blankson S et al (1993) A clinicopathologic study of 100 cases of Parkinson\u2019s disease [J]. Arch Neurol 50(2):140\u2013148","journal-title":"Arch Neurol"},{"issue":"10","key":"2756_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","volume":"40","author":"J JANKOVIC","year":"1990","unstructured":"Jankovic J, Mcdermott M, Carter J et al (1990) Variable expression of Parkinson\u2019s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group [J]. Neurology 40(10):1529\u20131534","journal-title":"Neurology"},{"key":"2756_CR31","doi-asserted-by":"publisher","unstructured":"Kr\u00fcger R, Klucken J, Weiss D, T\u00f6nges L, Kolber P, Unterecker S, Lorrain M, Baas H, M\u00fcller T, Riederer P (2017) Classification of advanced stages of parkinson\u2019s disease: translation into stratified treatments. J Neural Transm 124(8):1015\u20131027 https:\/\/doi.org\/10.1007\/s00702-017-1707-x","DOI":"10.1007\/s00702-017-1707-x"},{"key":"2756_CR3","doi-asserted-by":"crossref","unstructured":"Lee SH, Park SM, Yeo ss et al (2022) Parkinson\u2019s disease subtyping using clinical features and biomarkers: literature review and preliminary study of subtype clustering [J]. Diagnostics (Basel Switzerland), 12(1)","DOI":"10.3390\/diagnostics12010112"},{"issue":"7","key":"2756_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1631\/jzus.B0900380","volume":"11","author":"W LUO","year":"2010","unstructured":"Luo W, Gui XH, Wang B et al (2010) Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson\u2019s Disease Questionnaire (PDQ-39) [J]. J Zhejiang Univ Sci B 11(7):531\u2013538","journal-title":"J Zhejiang Univ Sci B"},{"key":"2756_CR22","doi-asserted-by":"publisher","unstructured":"Martinez-Martin P, Kulisevsky J, Mir P et al (2018) Validation of a simple screening tool for early diagnosis of advanced Parkinson\u2019s disease in daily practice: the CDEPA questionnaire [J], vol 4. NPJ Parkinson\u2019s disease, p 20 https:\/\/doi.org\/10.1038\/s41531-018-0056-2","DOI":"10.1038\/s41531-018-0056-2"},{"key":"2756_CR36","doi-asserted-by":"publisher","unstructured":"Mehanna R, Smilowska K, Fleisher J, Post B, Hatano T, Pimentel Piemonte ME, Kumar KR, McConvey V, Zhang B, Tan EK, Savica R (2022) Age cutoff for early\u2010onset parkinson\u2019s disease: recommendations from the international parkinson and movement disorder society task force on early onset parkinson\u2019s disease. ABSTRACT Mov Disord Clin Pract 9(7):869\u2013878. https:\/\/doi.org\/10.1002\/mdc3.13523","DOI":"10.1002\/mdc3.13523"},{"issue":"3","key":"2756_CR18","first-page":"69","volume":"24","author":"MM MUKAKA","year":"2012","unstructured":"Mukaka MM (2012) Statistics corner: a guide to appropriate use of correlation coefficient in medical research [J]. Malawi Med Journal: J Med Association Malawi 24(3):69\u201371","journal-title":"Malawi Med Journal: J Med Association Malawi"},{"issue":"4","key":"2756_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"V NASREDDINE Z S, PHILLIPS N A, B\u00e9DIR","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment [J]. J Am Geriatr Soc 53(4):695\u2013699","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 1","key":"2756_CR16","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1007\/PL00007730","volume":"245","author":"V PETO","year":"1998","unstructured":"Peto V, Jenkinson C (1998) PDQ-39: a review of the development, validation and application of a Parkinson\u2019s disease quality of life questionnaire and its associated measures [J]. J Neurol 245(Suppl 1):S10\u2013S14","journal-title":"J Neurol"},{"key":"2756_CR33","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"Ronald F. Pfeiffer","year":"2016","unstructured":"Pfeiffer RF (2016) Non-motor symptoms in Parkinson\u2019s disease [J]. Parkinsonism Relat Disord 22(Suppl 1):S119\u2013S122. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.004","journal-title":"Parkinsonism &amp; Related Disorders"},{"issue":"10","key":"2756_CR28","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/mds.21667","volume":"23","author":"S RAHMAN","year":"2008","unstructured":"Rahman S, Griffin HJ, Quinn NP et al (2008) Quality of life in Parkinson\u2019s disease: the relative importance of the symptoms [J]. Mov Disord 23(10):1428\u20131434","journal-title":"Mov Disord"},{"key":"2756_CR32","doi-asserted-by":"publisher","unstructured":"Ray Chaudhuri K, Rojo JM, Schapira AH, Brooks DJ, Stocchi F, Odin P, Antonini A, Brown RJ, Martinez-Martin P (2013) A proposal for a comprehensive grading of Parkinson\u2019s disease severity combining motor and non-motor assessments: meeting an unmet need [J]. PLoS ONE 8(2):e57221. https:\/\/doi.org\/10.1371\/journal.pone.0057221","DOI":"10.1371\/journal.pone.0057221"},{"key":"2756_CR7","doi-asserted-by":"publisher","first-page":"601225","DOI":"10.3389\/fneur.2020.601225","volume":"11","author":"J REN","year":"2020","unstructured":"Ren J, Hua P, Li Y et al (2020) Comparison of three motor subtype classifications in de novo Parkinson\u2019s Disease patients [J]. Front Neurol 11:601225","journal-title":"Front Neurol"},{"key":"2756_CR9","doi-asserted-by":"crossref","unstructured":"Santos Garc\u00eda D, \u00c1Lvarez Sauco M, Calopa M et al (2021) MNCD: A new tool for classifying Parkinson\u2019s disease in daily clinical practice [J]. Diagnostics (Basel, Switzerland), 12(1)","DOI":"10.3390\/diagnostics12010055"},{"issue":"3","key":"2756_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3233\/JPD-225073","volume":"13","author":"D SANTOS-GARC\u00edA","year":"2023","unstructured":"Santos-Garc\u00eda D, De Deus Fonticoba T, Cores Bartolom\u00e9 C et al (2023a) Staging Parkinson\u2019s Disease according to the MNCD (Motor\/Non-motor\/Cognition\/Dependency) classification correlates with Disease Severity and Quality of Life [J]. J Parkinson\u2019s Disease 13(3):379\u2013402","journal-title":"J Parkinson\u2019s Disease"},{"issue":"12","key":"2756_CR11","doi-asserted-by":"publisher","first-page":"e3295","DOI":"10.1002\/brb3.3295","volume":"13","author":"D SANTOS-GARC\u00edA","year":"2023","unstructured":"Santos-Garc\u00eda D, De Deus Fonticoba T, Cores Bartolom\u00e9 C et al (2023b) Staging Parkinson\u2019s disease according to the MNCD classification correlates with caregiver burden [J]. Brain Behav 13(12):e3295","journal-title":"Brain Behav"},{"key":"2756_CR35","doi-asserted-by":"publisher","unstructured":"Schrag A, Ben-Shlomo Y, Quinn NP (2000) Cross sectional prevalence survey of idiopathic parkinson\u2019s disease and parkinsonism in London. BMJ 321(7252):21\u201322 https:\/\/doi.org\/10.1136\/bmj.321.7252.21","DOI":"10.1136\/bmj.321.7252.21"},{"issue":"2","key":"2756_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.parkreldis.2013.10.005","volume":"20","author":"W SONG","year":"2014","unstructured":"Song W, Guo X, Chen K et al (2014) The impact of non-motor symptoms on the Health-Related Quality of Life of Parkinson\u2019s disease patients from Southwest China [J]. Parkinsonism Relat Disord 20(2):149\u2013152","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"2756_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"STEBBINS G T","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ et al (2013) How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale [J]. Mov Disord 28(5):668\u2013670","journal-title":"Mov Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02756-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T06:05:45Z","timestamp":1712988345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02756-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2756"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02756-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"22 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}